QUICK READ: Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science.
New Drug Launches
QUICK READ: While the emphasis within pharma has been to develop drugs to treat or prevent COVID-19 other new drugs are also being approved. It may be difficult to launch a drug to HCP’s during this time and a multichannel approach is needed.